CA 2024 * | 120 M 109 M | CA 2025 * | 130 M 118 M | Capitalisation | 97,03 M 88,12 M |
---|---|---|---|---|---|
Résultat net 2024 * | -16 M -14,53 M | Résultat net 2025 * | 1 M 908 k | VE / CA 2024 * | 0,81 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 0,75 x |
PER 2024 * |
-6
x | PER 2025 * |
204
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 97,77% |
Dernier transcript sur Depomed Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Heather Mason
CEO | Chief Executive Officer | 63 | 01/02/19 |
Ajay Patel
DFI | Director of Finance/CFO | 40 | 01/07/19 |
Howard Franklin
CTO | Chief Tech/Sci/R&D Officer | - | 06/03/23 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Peter Staple
CHM | Chairman | 72 | 01/11/03 |
James Tyree
BRD | Director/Board Member | 71 | 01/10/16 |
William McKee
BRD | Director/Board Member | 62 | 01/03/17 |
Varia. 1 janv. | Capi. | |
---|---|---|
+32,06% | 694 Md | |
+29,38% | 593 Md | |
-1,62% | 371 Md | |
+19,80% | 331 Md | |
+6,70% | 290 Md | |
+14,17% | 239 Md | |
-2,99% | 209 Md | |
+10,05% | 209 Md | |
+8,07% | 169 Md |